Results 1 to 10 of about 540,622 (219)

Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

Current Oncology, 2023
(1) Background: recent evidence suggests that long low-dose capecitabine regimens have a synergistic effect with endocrine therapy as aromatase inhibitors (AIs), and might increase overall survival for hormone-receptor-positive, HER2-negative, metastatic
Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R. Muñoz-Montaño, Juan W. Zinser-Sierra, Paula Anel Cabrera Galeana, Cynthia Villarreal Garza, Daniel Sanchez Benitez, Jesús Alberto Limón Rodríguez, Claudia Haydee Arce Salinas, Alberto Guijosa, Oscar Arrieta   +10 more
doaj   +1 more source

Preliminary results using a kit to measure tamoxifen and metabolites concentrations in capillary blood samples from women with breast cancer

Scientific Reports, 2022
The aim of the study was to compare 3 blood sampling methods, including capillary blood sampling, for determining Tamoxifen (TAM), Z-endoxifen (END), and 4-hydroxytamoxifen (4HT) concentrations.
Stefan Rehnmark, Ivan Shabo, Håkan Randahl, Yvonne Wengström, Per Rydberg, Elham Hedayati   +5 more
doaj   +1 more source

Seasonal variation in calcium treatment after thyroidectomy as surrogate for post-operative hypocalcemia: a retrospective register-based national cohort study

Thyroid Research, 2022
Background Hypocalcemia is one of the most common complications of thyroidectomy, and vitamin D deficiency has been found to be an independent risk factor. Sweden is located north of the 55th latitude, resulting in a significant seasonal variation in sun
Carl Kördel, Anna Koman, Robert Bränström, Adam Stenman   +3 more
doaj   +1 more source

Adrenal cortical adenoma arising in an adreno-hepatic fusion: Case report and literature review of a potential diagnostic pitfall

Human Pathology Reports, 2022
Adrenal incidentalomas are commonly detected via routine radiological procedures, and any sign of grossly invasive properties may alert the clinical team to suspect malignancy.
Adam Stenman, Ivan Shabo, Jan Zedenius, C. Christofer Juhlin   +3 more
doaj   +1 more source

A clinical case of multiple primary cancers in a carrier of rare SDK2 and NOTCH2 gene mutations

Egyptian Journal of Medical Human Genetics, 2021
Background Genetic predisposition is one of the risk factors for the development of multiple primary cancers (MPCs), the frequency of which increases and ranges from 2 to 17%.
Nataliya N. Timoshkina, Dmitry Y. Gvaldin, Ekaterina P. Omelchuk, Larisa N. Vashhenko, Tatjana V. Ausheva, Emma E. Kechedzhieva, Oleg I. Kit   +6 more
doaj   +1 more source

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?

Thyroid Research, 2021
Background Thyroid cancer dedifferentiation is an unusual observation among young patients and is poorly understood, although a recent correlation to DICER1 gene mutations has been proposed.
Klara Johansson, Adam Stenman, Johan O. Paulsson, Na Wang, Catharina Ihre-Lundgren, Jan Zedenius, C. Christofer Juhlin   +6 more
doaj   +1 more source

SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer

Frontiers in Pharmacology, 2022
Colorectal cancer (CRC) is one of the most lethal cancers of the digestive system. The tumor microenvironment (TME) plays a central role in the initiation and development of CRC.
Yiming Ma, Lei Zhan, Jun Yang, Jingdong Zhang   +3 more
doaj   +1 more source

Pilomatrixoma of the Male Breast: Case Report and Literature Review

Oman Medical Journal, 2023
Pilomatrixoma is a rare benign skin adnexal tumor arising from the hair follicles. Its occurrence in the male breast is extremely uncommon with very few cases reported worldwide.
Maryam Al-Issai, Salim Al-Rahbi, Anfal Al-Futaisi, Uday Arun Gokhale, Samya Al-Salhi   +4 more
doaj   +1 more source

Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature

Journal of Medical Case Reports, 2020
Background Metastatic neuroendocrine carcinoma often presents as carcinoma of unknown primary. Although most cases display immunohistochemical positivity for neuroendocrine markers, subsets of cases display reduced or negative expression for some of ...
Carl Christofer Juhlin, Jan Zedenius, Felix Haglund   +2 more
doaj   +1 more source

Maximum intensity projection based on high frame rate contrast-enhanced ultrasound for the differentiation of breast tumors

Frontiers in Oncology, 2023
ObjectiveWe explored the role of maximum intensity projection (MIP) based on high frame rate contrast-enhanced ultrasound (H-CEUS) for the differentiation of breast tumors.MethodsMIP imaging was performed in patients with breast tumors who underwent H ...
Jia Li, Cong Wei, Xinxin Ma, Tao Ying, Di Sun, Yuanyi Zheng   +5 more
doaj   +1 more source